Science & Innovation
The potential to transform patient lives drives us at Biogen
We work in disease areas with some of the greatest unmet need. We work relentlessly, knowing that bold new possibilities await discovery. As a leading global biotechnology company, we work toward those life-changing moments that could become a historic points in our pursuit of innovative treatments.
Our world-class neurology research and development organization is pushing toward novel approaches for previously intractable neurodegenerative conditions such as Alzheimer’s disease.
Learn more
For over a decade, Biogen has been committed to advancing ALS research to provide a deeper understanding of all forms of this devastating disease.
Learn more
Biogen is proud to leverage our expertise in rare diseases to help address the unmet needs of the FA community.
Learn more
Biogen has pioneered the development of MS treatments for more than 25 years. We continue to innovate to advance MS treatment and improve outcomes for patients. Our research is focused on potentially transformative therapies, including the potential repair of the damage caused by MS.
Learn more
We are committed to advancing innovative research on the pathophysiology of mental health conditions and strive to advance screening and treatment for postpartum depression and pioneer much-needed solutions to improve maternal mental health outcomes.
Biogen is dedicated to enhancing the lives of those with SMA and their families through ongoing research, removing barriers to access and providing support programs. In December 2017, Biogen launched a collaboration with Ionis to identify new therapeutic options — specifically, new antisense oligonucleotide (ASO) candidates, which are designed to treat SMA — for individuals afflicted with the debilitating disease.